Global 500

Rank
496
Previous: 495 Next: 497

Teva Pharmaceutical Industries

G500 2017—Teva Pharmaceutical Industries
An employee collects newly-manufactured pills at the tablet production plant at Teva Pharmaceutical Industries Ltd.'s headquarters in Jerusalem, Israel, on Monday, Sept. 19, 2011. Teva, the world's largest maker of generic drugs, will invest $19 million in the CureTech Ltd. unit of Clal Biotechnology Industries Ltd. Adam Reynolds—Bloomberg/Getty Images
  • Previous Rank
  • Revenues ($M)
    21903
  • Revenue Percent Change
    11.5
  • Profits ($M)
    329
  • Profits Percent Change
    -79.3
  • Assets ($M)
    92890
  • Employees
    56960

Company Information

CEOYitzhak Peterburg
SectorHealth Care
IndustryPharmaceuticals
HQ LocationPetach Tikva, Israel
Websitewww.tevapharm.com
Years on Global 500 List1
Employees56,960

Key Financials (Last Fiscal Year)

Revenues ($M)$21,903
Profits ($M)$329
Assets ($M)$92,890
Total Stockholder Equity ($M)$33,337

Profit Ratios

Profit as % of Revenues1.5%
Profits as % of Assets0.4%
Profits as % of Stockholder Equity1%